U.S. Rare Disease Diagnostics Market is projected to grow to USD 28,567.83 million by 2032, to grow at a CAGR of 9.3% from 2024 to 2032 | PMR

Growing awareness among healthcare professionals about rare diseases is a significant factor driving the demand for rare disease diagnostics. Besides, increased awareness has led to medical professionals offering apt diagnostic tests tailored to suspected rare diseases, thereby supporting the U.S. rare disease diagnostics industry growth.

The global U.S. rare disease diagnostics market size was valued at USD 12,875.84 million in 2023. The industry is projected to grow to USD 28,567.83 million by 2032, exhibiting a CAGR of 9.3% during the forecast period from 2024 to 2032. 

𝘿𝙤𝙬𝙣𝙡𝙤𝙖𝙙 𝙁𝙧𝙚𝙚 𝙎𝙖𝙢𝙥𝙡𝙚 𝙋𝘿𝙁 𝘾𝙤𝙥𝙮 𝙤𝙛 𝙩𝙝𝙚 𝙍𝙚𝙥𝙤𝙧𝙩: https://www.polarismarketresearch.com/industry-analysis/us-rare-disease-diagnostics-market/request-for-sample

A rare disease, also known as an orphan disease, is an uncommon medical condition that affects a small percentage of the population. Rare diseases are broadly classified into two types, which are primary rare diseases and secondary rare diseases. Primary rare diseases occur as a result of a genetic or congenital defect, whereas secondary rare diseases occur due to exposure to a toxic substance.

Rare disease diagnostics is concerned with the identification and diagnosis of a rare disease. It aims at improving illness management, better identification of promising drugs, and avoidance of needless medications that might have harmful side effects. The benefits of getting rare disease diagnosis include uniform disease management, reduced costs, reproductive therapy, and societal advantages. 

𝙏𝙤𝙥 𝙈𝙖𝙧𝙠𝙚𝙩 𝙋𝙖𝙧𝙩𝙞𝙘𝙞𝙥𝙖𝙣𝙩𝙨: 

The U.S. rare disease diagnostics market has the presence of large diagnostic companies with diverse portfolios. These industry players leverage their expertise in molecular diagnostics and special laboratories to garner a larger revenue share. Among the top industry players include:

Agilent Technologies, Inc.
Ambry Genetics
Arup Laboratories
FDNA INC
GeneDx, LLC
Illumina, Inc.
Invitae Corporation
Laboratory Corporation of America Holdings
Quest Diagnostics

𝙄𝙣𝙦𝙪𝙞𝙧𝙚 𝙢𝙤𝙧𝙚 𝙖𝙗𝙤𝙪𝙩 𝙩𝙝𝙞𝙨 𝙧𝙚𝙥𝙤𝙧𝙩 𝙗𝙚𝙛𝙤𝙧𝙚 𝙥𝙪𝙧𝙘𝙝𝙖𝙨𝙚 @ https://www.polarismarketresearch.com/industry-analysis/us-rare-disease-diagnostics-market/inquire-before-buying

𝙐.𝙎. 𝙍𝙖𝙧𝙚 𝘿𝙞𝙨𝙚𝙖𝙨𝙚 𝘿𝙞𝙖𝙜𝙣𝙤𝙨𝙩𝙞𝙘𝙨 𝙈𝙖𝙧𝙠𝙚𝙩 𝙍𝙚𝙥𝙤𝙧𝙩 𝙃𝙞𝙜𝙝𝙡𝙞𝙜𝙝𝙩𝙨

In 2023, inherited segment held the largest share in the U.S. rare disease diagnostics market. The growing awareness of inherited diseases among healthcare professionals, patients, and the general public. Screening programs for genetic disorders, such as newborn screening and carrier screening, have become more widespread, leading to early detection and diagnosis of inherited diseases. As a result, the demand for inherited diseases diagnostics has increased significantly in recent years.

The diagnostic laboratories segment is expected to grow at the fastest CAGR over the forecasted years. As awareness of rare diseases grows and healthcare providers increasingly recognize the importance of early and accurate diagnosis, the demand for specialized testing services provided by diagnostic laboratories is expected to rise significantly.

𝙍𝙚𝙜𝙞𝙤𝙣𝙖𝙡 𝘼𝙣𝙖𝙡𝙮𝙨𝙞𝙨:

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

𝐀𝐜𝐜𝐞𝐬𝐬 𝐓𝐡𝐞 𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭, 𝐡𝐞𝐫𝐞: https://www.polarismarketresearch.com/industry-analysis/us-rare-disease-diagnostics-market

𝙎𝙚𝙜𝙢𝙚𝙣𝙩𝙖𝙡 𝙊𝙫𝙚𝙧𝙫𝙞𝙚𝙬:

The market is primarily segmented based on disease type, product type, sample type, technology, test type, age, trait type, and end use.
Based on a trait type analysis, the inherited segment held the largest market share in 2023, as inherited or genetic diseases represent a significant portion of rare diseases. 
By end use insights, the diagnostic laboratories segment is expected to grow at the fastest rate in the U.S. rare disease diagnostics market as diagnostic labs offer specialized testing services. 
 

𝐓𝐨𝐩 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐛𝐲 𝐏𝐨𝐥𝐚𝐫𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡:
𝘿𝙚𝙣𝙩𝙖𝙡 𝙇𝙖𝙗𝙤𝙧𝙖𝙩𝙤𝙧𝙞𝙚𝙨 𝙈𝙖𝙧𝙠𝙚𝙩: https://www.polarismarketresearch.com/industry-analysis/dental-laboratories-market
𝙄𝙣𝙛𝙚𝙘𝙩𝙞𝙤𝙪𝙨 𝘿𝙞𝙨𝙚𝙖𝙨𝙚 𝘿𝙞𝙖𝙜𝙣𝙤𝙨𝙩𝙞𝙘𝙨 𝙈𝙖𝙧𝙠𝙚𝙩: https://www.polarismarketresearch.com/industry-analysis/infectious-disease-diagnostic-market
𝙈𝙚𝙙𝙞𝙘𝙖𝙡 𝙁𝙤𝙤𝙙𝙨 𝙈𝙖𝙧𝙠𝙚𝙩: https://www.polarismarketresearch.com/industry-analysis/medical-foods-market
𝙎𝙚𝙢𝙞𝙘𝙤𝙣𝙙𝙪𝙘𝙩𝙤𝙧 𝙈𝙚𝙢𝙤𝙧𝙮 𝙈𝙖𝙧𝙠𝙚𝙩: https://www.polarismarketresearch.com/industry-analysis/semiconductor-memory-marke
𝘿𝙚𝙣𝙩𝙖𝙡 𝙇𝙖𝙨𝙚𝙧𝙨 𝙈𝙖𝙧𝙠𝙚𝙩: https://www.polarismarketresearch.com/industry-analysis/dental-lasers-market

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐈𝐧𝐟𝐨:
Polaris Market Research
30 Wall Street, 8th Floor,
New York City, NY 10005,
United States
Phone:+1-929 297-9727
Email: sales@polarismarketresearch.com

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:
Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defence, among different ventures present globally.

This release was published on openPR.